Enovis Corporation

NYSE:ENOV

Medical - Devices

Healthcare
$27.10 +3.50%

+$0.73 today

Market cap
$1.56B
Beta
1.49
P/E (TTM)
-1.1
EPS (TTM)
-$20.02
52W Low $20.55High $36.82

Volume 0.88M

Average 0.99M

ENOV Total Equity

Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.

Enovis CorporationNYSE: ENOV

Total Equity · Q1 FY2026 · quarter ended Apr 2026

Total equity falls 43.5% from a year ago

Total equity stood at $1.48B at the end of Q1 FY2026, down 43.5% from a year earlier and down 0.8% from the prior quarter. Over 3 fiscal years it compounded at -24.4% a year.

Context

  • Total equity amounted to 38.6% of total assets at the end of Q1 FY2026, down 15.1 pp from a year earlier.
  • Total equity increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether total equity keeps falling in the next quarterly balance sheet after a -43.5% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterApr 2026
$1.48B-0.8% QoQ
Last fiscal yearDec 2025
$1.49B-41.8% YoY
Year agoApr 2025
$2.62B-43.5% since
Total Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-43.5%——
1 year-41.8%——
3-year CAGR-24.4%——
5-year CAGR——
10-year CAGR——

Total Equity history

USD · from the balance sheet

Latest · FY2025
1.49B USD
Year-over-year change
-41.8%
4-year CAGR
-24.8%

Total Equity vs competitors

How ENOV compares with its peers on the latest reported figures

  • ENOV's Apr 2026 total equity of $1.48B is the 7th highest of the 16 companies compared; the peer median is $1.03B.
  • Its year-over-year change of -43.5% is the lowest of 16, against a peer median of +6.1%.
  • Total equity amounts to 38.6% of total assets for ENOV, versus a peer median of 55.0%.
ENOV Competitors Peer median
Total Equity for ENOV and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ITTITT Inc.Jul 2026$4.81B +87.6%+21.9%43.6%
IEXIDEX CorporationJun 2026$4.01B -0.1%+9.8%57.8%
MIDDThe Middleby CorporationJul 2026$2.21B -39.0%-0.3%41.2%
WTSWatts Water Technologies, Inc.Jun 2026$2.19B +15.7%+16.0%74.2%
DCIDonaldson Company, Inc.Jul 2026$1.76B +21.4%+10.1%44.3%
NPOEnPro Industries, Inc.Jun 2026$1.59B +6.1%+3.0%59.7%
ENOVEnovis CorporationApr 2026$1.48B -43.5%-24.4%38.6%
FELEFranklin Electric Co., Inc.Sep 2026$1.45B +9.6%+7.4%55.0%
KAIKadant Inc.Jul 2026$1.03B +10.3%+14.8%54.7%
HLIOHelios Technologies, Inc.Jul 2026$948.3M +4.0%+5.4%62.6%
GRCThe Gorman-Rupp CompanyJun 2026$441.43M +11.0%+7.8%50.9%
EPACEnerpac Tool Group Corp.Feb 2026$407.54M +0.4%+10.7%51.2%
LXFRLuxfer Holdings PLCMar 2026$223.5M -1.4%+3.0%57.0%
HURCHurco Companies, Inc.Apr 2026$192.42M -4.9%-3.7%74.2%
GHMGraham CorporationMar 2026$140.32M +17.3%+13.1%43.4%
OFLXOmega Flex, Inc.Mar 2026$82.61M -0.8%+5.7%81.5%
Peer median (excluding ENOV) $1.03B+6.1%+7.8%55.0%

Competitors are the stored peer set for ENOV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents680.25M24.3M36.19M48.17M36.39M
Short-term Investments00000
Net Receivables254.96M267.38M291.48M407.03M442.79M
Inventory356.23M426.64M468.83M547.12M584.38M
Other Current Assets985.79M48.16M71.11M107.88M101.22M
Total Current Assets2.3B795.02M896.52M1.15B1.21B
Property, Plant & Equipment (Net)311.6M303.62M334.3M473.42M579.32M
Goodwill1.93B1.98B2.06B1.69B718.3M
Intangible Assets1.15B1.11B1.13B1.32B1.24B
Long-term Investments15.42M16.5M020.4M21.4M
Tax Assets0(16.5M)000
Other Non-current Assets2.8B80.29M90.26M68.38M71.95M
Total Non-current Assets6.21B3.48B3.61B3.57B2.63B
Total Assets8.52B4.27B4.51B4.72B3.83B
Account Payables155.21M135.63M132.48M179.1M187.53M
Short-term Debt29.64M243.56M21.57M20.03M59.74M
Tax Payables72.28M13.68M14.38M21.34M0
Deferred Revenue9.2M3.56M2.95M6.23M6.5M
Other Current Liabilities736.57M101.72M114.21M188.97M212.42M
Total Current Liabilities1.02B565.2M369.61M529M598.47M
Long-term Debt2.08B40M466.16M1.31B1.26B
Deferred Tax Liabilities0000102.7M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities695.72M166.99M204.18M263.52M321.87M
Total Non-current Liabilities2.83B258.25M719.03M1.63B1.74B
Total Liabilities3.85B823.45M1.09B2.15B2.34B
Common Stock52K54K55K56K57K
Retained Earnings589.02M575.73M542.47M(283.02M)(1.47B)
Accumulated OCI(516.01M)(53.43M)(24.88M)(127.89M)(91.36M)
Other Stockholders Equity00000
Minority Interest44.06M1.72M2.31M2.07M2.26M
Total Equity4.66B3.45B3.42B2.56B1.49B
Total Debt2.16B334.82M536.42M1.4B1.38B
Net Debt1.48B310.52M500.23M1.36B1.34B

Enovis Corporation

NYSE:ENOV

Intrinsic Alpha fair value

Locked

Current Price

$27.10

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.